Clinical Study

Nitazoxanide in Acute Rotavirus Diarrhea: A Randomized Control Trial from a Developing Country

Table 2

Primary and secondary outcome measures.

Nitazoxanide group Control group Difference [95% CI]

Median (IQR) hours of diarrhea54 (45–65)80 (65–89)–26 [–13.2 to –38.8]
Median (IQR) hours of hospitalization68 (57–75)90 (77–93)–22 [–12.98 to –31.02]
Median (IQR) duration of fever (hours)43 (35–48)47 (42–52)–4 [–10.89 to 2.89]
Median (IQR) duration of vomiting (hours)38 (33–41)41 (35–46)–3 [–8.84 to 2.84]
Proportion (%) of children requiring parenteral rehydration1 (4)2 (8)0.48 [0.04 to 5.65]

The difference between the two medians and calculation of 95% CI (confidence interval) has been done by the method proposed by Bonett and Price [14].
Data expressed in odds ratio (OR) and 95% CI.